Selectins Ligand Decorated Drug Carriers for Activated Endothelial Cell Targeting

被引:25
作者
Banquy, Xavier [1 ]
Leclair, Gregoire [1 ,4 ]
Rabanel, Jean-Michel [1 ]
Argaw, Anteneh
Bouchard, Jean-Francois [3 ]
Hildgen, Patrice [1 ,3 ]
Giasson, Suzanne [1 ,2 ,3 ]
机构
[1] Univ Montreal, Fac Pharm, Ecole Optometrie, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada
[3] Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada
[4] Merck Frosst Canada Inc, Kirkland, PQ, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
D O I
10.1021/bc800257m
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
New active particulate polymeric vectors based on branched polyester copolymers of hydroxy-acid and allyl glycidyl ether were developed to target drugs to the inflammatory endothelial cell surface. The hydroxyl and carboxyl derivatives of these polymers allow grafting of ligand molecules on the polyester backbones at different densities. A known potent nonselective selectin ligand was selected and synthesized using a new scheme. This synthesis allowed the grafting of the ligand to the polyester polymers, preserving its binding activity as assessed by docking simulations. Selectin expression on human umbilical cord vascular endothelial cells (HUVEC) was induced with the pro-inflammatory bacterial lipopolysaccharide (LPS) or with the nonselective inhibitor of nitric oxide synthase L-NAME. Strong adhesion of the ligand decorated nanoparticles was evidenced in vitro on activated HUVEC. Binding of nanoparticles bearing ligand molecules could be efficiently inhibited by prior incubation of cells with free ligand, demonstrating that adhesion of the nanoparticles is mediated by specific interaction between the ligand and the selectin receptors. These nanoparticles could be used for specific drug delivery to the activated vascular endothelium, suggesting their application in the treatment of diseases with an inflammatory component such as rheumatoid arthritis and cancer.
引用
收藏
页码:2030 / 2039
页数:10
相关论文
共 36 条
[1]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]   Regulation of P-selectin expression in human endothelial cells by nitric oxide [J].
Armstead, VE ;
Minchenko, AG ;
Schuhl, RA ;
Hayward, R ;
Nossuli, TO ;
Lefer, AM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (02) :H740-H746
[3]  
Bendas G, 1998, Pharm Acta Helv, V73, P19, DOI 10.1016/S0031-6865(97)00043-5
[4]  
Bhaskar V, 2003, CANCER RES, V63, P6387
[5]   Modulation of K+ currents in monocytes by VCAM-1 and E-selectin on activated human endothelium [J].
Colden-Stanfield, M ;
Gallin, EK .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 275 (01) :C267-C277
[6]   Sialyl Lewis x liposomes as a multivalent ligand and inhibitor of E-selectin mediated cellular adhesion [J].
DeFrees, SA ;
Phillips, L ;
Guo, L ;
Zalipsky, S .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (26) :6101-6104
[7]   Selectins - an emerging target for drug delivery [J].
Ehrhardt, C ;
Kneuer, C ;
Bakowsky, U .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (04) :527-549
[8]   Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes - II: effect of degradation on targeting activity [J].
Eniola, AO ;
Hammer, DA .
BIOMATERIALS, 2005, 26 (06) :661-670
[9]   Comparison of E-selectin expression at mRNA and protein levels in murine models of inflammation [J].
Everts, M ;
Asgeirsdóttir, SA ;
Kok, RJ ;
Twisk, J ;
de Vries, B ;
Lubberts, E ;
Bos, EJ ;
Werner, N ;
Meijer, DKF ;
Molema, G .
INFLAMMATION RESEARCH, 2003, 52 (12) :512-518
[10]   Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin-directed immunoconjugate [J].
Everts, M ;
Kok, RJ ;
Asgeirsdóttir, SA ;
Melgert, BN ;
Moolenaar, TJM ;
Koning, GA ;
van Luyn, MJA ;
Meijer, DKF ;
Molema, G .
JOURNAL OF IMMUNOLOGY, 2002, 168 (02) :883-889